Creative Planning
ANIP icon

Creative Planning’s ANI Pharmaceuticals ANIP Stock Holding History

Creative Planning’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
+3,173
New +$255K ﹤0.01% 3676
2025
Q1 		– Sell
-90
Closed -$4.97K – 3477
2024
Q4 		$4.97K Buy
+90
New +$5.17K ﹤0.01% 3412
2018
Q3 		– Sell
-5,093
Closed -$340K – 2077
2018
Q2 		$340K Sell
5,093
-30
-0.6% -$1.87K ﹤0.01% 1291
2018
Q1 		$298K Buy
+5,123
New +$325K ﹤0.01% 1344
2017
Q3 		– Sell
-2,218
Closed -$104K – 1967
2017
Q2 		$104K Sell
2,218
-296
-12% -$14.3K ﹤0.01% 1965
2017
Q1 		$124K Buy
2,514
+2,047
+438% +$115K ﹤0.01% 1820
2016
Q4 		$28K Sell
467
-12
-3% -$734 ﹤0.01% 2838
2016
Q3 		$32K Buy
479
+28
+6% +$1.75K ﹤0.01% 2684
2016
Q2 		$25K Sell
451
-125
-22% -$6.08K ﹤0.01% 2631
2016
Q1 		$19K Hold
576
– – ﹤0.01% 2778
2015
Q4 		$26K Hold
576
– – ﹤0.01% 2631
2015
Q3 		$23K Buy
+576
New +$32.8K ﹤0.01% 2619
2015
Q2 		– Sell
-687
Closed -$43K – 1186
2015
Q1 		$43K Buy
687
+485
+240% +$29.5K ﹤0.01% 2113
2014
Q4 		$11K Buy
+202
New +$8.91K ﹤0.01% 3052
2013
Q4 		– Sell
-1
Closed – – 3305
2013
Q3 		$0 Buy
+1
New +$7 ﹤0.01% 3201

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Planning's ANIP Position: Q2 2026 in Review

Creative Planning opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 3,173 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #3676 among its holdings. This is a return to the name: Creative Planning previously reported a position in ANIP as recently as Q4 2024.

Creative Planning first reported a position in ANIP in Q3 2013 and has held it in 15 quarters since. The position peaked at $340K in Q2 2018. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Creative Planning held 3,173 shares of ANI Pharmaceuticals worth $263K as of Q2 2026.
  • ANI Pharmaceuticals was a new Creative Planning position in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3676 holding.
  • Creative Planning first reported a position in ANI Pharmaceuticals in Q3 2013 and has held it in 15 quarters since.
  • Creative Planning's ANI Pharmaceuticals position peaked at $340K in Q2 2018.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.